Article
Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia.
Pharmacogenomics - 1 Jun 2014
Ceppi Francesco, Langlois-Pelletier Chloé, Gagné Vincent, Rousseau Julie, Ciolino Claire, De Lorenzo Samanta, Kevin Kojok M, Cijov Diana, Sallan Stephen E, Silverman Lewis B, Neuberg Donna, Kutok Jeffery L, Sinnett Daniel, Laverdière Caroline, Krajinovic Maja
Abstract excerpt
BACKGROUND: Vincristine (VCR) is a standard component in the treatment of childhood acute lymphoblastic leukemia (ALL). VCR cytotoxicity is primarily due to its ability to disrupt the formation of microtubules of the mitotic spindle. PATIENTS & METHODS: Seventeen polymorphisms in regulatory and coding regions of genes controlling VCR targets (TUBB1, MAP4, ACTG1 and CAPG) or potentially influencing VCR levels...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
